Literature DB >> 20183726

Contrast sensitivity in children with and without attention deficit hyperactivity disorder symptoms.

Jami Bartgis1, Elizabeth K Lefler, Cynthia M Hartung, David G Thomas.   

Abstract

Dopamine regulation may play a role in attention-deficit hyperactivity disorder (ADHD). Visual contrast sensitivity has been proposed as a measure of retinal dopamine that may predict frontal lobe dopamine levels. Individuals with disorders involving dopamine dysregulation (e.g., Parkinson's disease, Phenylketonuria) have shown poor contrast sensitivity. In this study, 110 6- to 13-year-old children with and without ADHD completed a task measuring visual contrast sensitivity. As predicted, contrast sensitivity was significantly worse in children with ADHD-Combined Type than controls. Contrast sensitivity was significantly correlated with inattention and hyperactivity. However, unlike many neuropsychological studies of ADHD, only hyperactivity accounted for unique variance.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20183726     DOI: 10.1080/87565640902964474

Source DB:  PubMed          Journal:  Dev Neuropsychol        ISSN: 1532-6942            Impact factor:   2.253


  3 in total

1.  Association between ADHD and vision problems. A systematic review and meta-analysis.

Authors:  Alessio Bellato; John Perna; Preethi S Ganapathy; Marco Solmi; Andrea Zampieri; Samuele Cortese; Stephen V Faraone
Journal:  Mol Psychiatry       Date:  2022-08-05       Impact factor: 13.437

2.  Diverse patterns of vulnerability to visual illusions in children with neurodevelopmental disorders.

Authors:  Gerasimos Makris; Panagiota Pervanidou; Giorgos Chouliaras; Xanthi Stachtea; Eleni Valavani; Despoina Bastaki; Panagiota Korkoliakou; Paraskevi Bali; Kiriaki Poulaki; George P Chrousos; Charalabos Papageorgiou
Journal:  Cogn Process       Date:  2021-06-21

3.  Retinal contrast transfer functions in adults with and without ADHD.

Authors:  Emanuel Bubl; Michael Dörr; Alexandra Philipsen; Dieter Ebert; Michael Bach; Ludger Tebartz van Elst
Journal:  PLoS One       Date:  2013-05-02       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.